Randomized, double-blind, phase II clinical trial to evaluate maintenance with olaparib versus placebo in platinum-sensitive advanced non-small cell lung cancer patients
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: INSTITUT GUSTAVE ROUSSY
- Phase: II
- Execution start: 06/10/2015
- End of execution: 31/12/2020
- IP: